Lean Dry Gout Patients

  • L. G. Darlington
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 165)


Hypertriglyceridaemia is common in gout (1,2). There is good evidence that the hyperprebetalipoproteinaemia of gout patients may be associated with obesity and excessive alcohol consumption (3). It remains uncertain, however, whether obesity and alcohol, either alone or in combination, are sufficient to explain the hyperlipidaemia in all cases.


Uric Acid Serum Uric Acid Uric Acid Level Serum Uric Acid Level Excessive Alcohol Consumption 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. G. Darlington, and J. T. Scott, Plasma lipid levels in gout. Ann. Rheum Dis. 31:487–489 (1972).PubMedCrossRefGoogle Scholar
  2. 2.
    H. Mielants, E. M. Veys and A. de Weerdt, Gout and its relation to lipid metabolism. I. Serum uric acid, lipid and lipoprotein levels in gout. Ann Rheum Dis. 32: 501–505 (1973).PubMedCrossRefGoogle Scholar
  3. 3.
    T. Gibson and R. Grahame, Gout and hyperlipidaemia, Ann Rheum Dis. 33: 298–303 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    Metropolitan Life Insurance Company Tables. Build and Blood Pressure Study, Society of Actuaries, Chicago, Illinois,U.S.A. (1959)Google Scholar
  5. 5.
    J. Slack, N. Noble, T. W. Meade, and W. R. S. North. Lipid and lipoprotein concentrations in 1,604 men and women in working populations in N.W.London. Br. Med. J. 2: 353–356 (1977).PubMedCrossRefGoogle Scholar
  6. 6.
    G. Trevaks and R. R. H. Lovell. Effect of Atromid and its components on uric acid excretion and on gout. Ann Rheum Dis. 24: 572–575 (1965).PubMedCrossRefGoogle Scholar
  7. 7.
    W. S. Aronow, P. R. Harding, M. Khursheed, J. S. Vangrow and N. P. Papageorges. Effect of halofenate on serum uric acid. Clin. Pharmacol. Therap. 14: 371–373 (1973).Google Scholar
  8. 8.
    R. Bluestone, B.Lewis and L. Mervart. Hyperlipoproteinaemia in gout. Ann. Rheum Dis. 30: 134–137 (1971)PubMedCrossRefGoogle Scholar
  9. 9.
    D. G. MacFarlane, C. A. Midwinter, P. A. Hopes, B. Slade, P. A. Dieppe Lipoproteins, gout, and vascular disease. Ann Rheum Dis 41: 200 (1982)Google Scholar
  10. 10.
    E. Wiedemann, H.G. Rose and E. Schwartz,. Plasma lipoproteins, Glucose Tolerance and Insulin response in Primary Gout. Amer. J. Med. 53: 299–307 (1972).CrossRefGoogle Scholar
  11. 11.
    T. Gibson, K. Kilbourn, I. Horner and H. A. Simmonds. Mechanism and treatment of hypertriglyceridaemia in gout. Ann Rheum Dis. 38: 31–35 (1979).PubMedCrossRefGoogle Scholar
  12. 12.
    L. G. Darlington, J. Slack and J. T. Scott. Family study of lipid and purine levels in gout patients. Ann. Rheum. Dis. In press.Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • L. G. Darlington
    • 1
  1. 1.Epsom District HospitalEpsom, SurreyUK

Personalised recommendations